Importance of protection of antimalarial combination therapies [4]

Lancet

Volumn 364, Issue 9447, 2004, Pages 1754-1755

  Duong, Socheat ^a   Lim, Pharath ^b   Fandeur, Thierry ^b   Tsuyuoka, Reiko ^c   Wongsrichanalai, Chansuda ^d  

^a Natl Ctr Parasitol Entomol M   (Cambodia)

^b INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d US Naval Medical Research Unit No 2 Jakarta   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISIN; ARTESUNATE; MEFLOQUINE;

HUMAN; INFECTION PREVENTION; LETTER; MALARIA; MALARIA CONTROL; NONHUMAN; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; THAILAND;

EID: 8444242097     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)17391-1     Document Type: Letter

References (3)

1. Kremsner PG, Krishna S. Antimalarial combinations. Lancet. 364:2004;285-294
2. Wongsrichanalai C, Prajakwong S, Meshnick SR, Shanks GD, Thimasarn K. Mefloquine: its 20 years in the Thai malaria control program. Southeast Asian J Trop Med Public Health. 35:2004;300-308
3. WHO. The use of antimalarial drugs: report of a WHO informal consultation, Nov 13-17, 2000. Geneva: World Health Organization, 2001. http://whqlibdoc.who.int/hq/2001/WHO_CDS_RBM_2001.33.pdf.